Overview
Martin Meliska practices in Prague, Czech Republic. Mr. Meliska is rated as an Experienced expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Optic Nerve Atrophy, Sorsby Fundus Dystrophy, Danon Disease, and Vitrectomy.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Danon DiseaseMr. Meliska isExperienced. Learn about Danon Disease.
- Leber Hereditary Optic Neuropathy (LHON)Mr. Meliska isExperienced. Learn about Leber Hereditary Optic Neuropathy (LHON).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Optic Nerve AtrophyMr. Meliska isExperienced. Learn about Optic Nerve Atrophy.
- Retinopathy Pigmentary Mental RetardationMr. Meliska isExperienced. Learn about Retinopathy Pigmentary Mental Retardation.
- Sorsby Fundus DystrophyMr. Meliska isExperienced. Learn about Sorsby Fundus Dystrophy.